BRPI0519561A2 - composiÇço farmacÊutica de hormânio da tireàide, embalagem farmacÊutica, e, mÉtodo de acondicionamento de uma composiÇço farmacÊutica de hormânio da tireàide - Google Patents

composiÇço farmacÊutica de hormânio da tireàide, embalagem farmacÊutica, e, mÉtodo de acondicionamento de uma composiÇço farmacÊutica de hormânio da tireàide

Info

Publication number
BRPI0519561A2
BRPI0519561A2 BRPI0519561-6A BRPI0519561A BRPI0519561A2 BR PI0519561 A2 BRPI0519561 A2 BR PI0519561A2 BR PI0519561 A BRPI0519561 A BR PI0519561A BR PI0519561 A2 BRPI0519561 A2 BR PI0519561A2
Authority
BR
Brazil
Prior art keywords
packaging
pharmaceutical composition
thyroid hormone
pharmaceutical
thyraid
Prior art date
Application number
BRPI0519561-6A
Other languages
English (en)
Inventor
Kyle E Brinkman
Dan Rutledge
Joseph R Bayman
Original Assignee
King Pharmaceuticals Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by King Pharmaceuticals Res & Dev filed Critical King Pharmaceuticals Res & Dev
Publication of BRPI0519561A2 publication Critical patent/BRPI0519561A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Packages (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)

Abstract

COMPOSIÇçO FARMACÊUTICA DE HORMâNIO DA TIREàIDE, EMBALAGEM FARMACÊUTICA, E, MÉTODO DE ACONDICIONAMENTO DE UMA COMPOSIÇçO FARMACÊUTICA DE HORMâNIO DA TIREàIDE. Nova embalagem, métodos de embalagem e métodos para armazenar composições farmacêuticas de hormônio da tireóide, tais que levotiroxina sódica (T3), em condições de oxigênio reduzidas, para a manutenção da estabilidade e potência dos hormônios da tireóide durante a vida em prateleira estendida, são providos.
BRPI0519561-6A 2004-12-27 2005-12-22 composiÇço farmacÊutica de hormânio da tireàide, embalagem farmacÊutica, e, mÉtodo de acondicionamento de uma composiÇço farmacÊutica de hormânio da tireàide BRPI0519561A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63932804P 2004-12-27 2004-12-27
US63934404P 2004-12-27 2004-12-27
PCT/US2005/047011 WO2006071844A2 (en) 2004-12-27 2005-12-22 Oxygen-impervious packaging and methods for storing thyroid hormone

Publications (1)

Publication Number Publication Date
BRPI0519561A2 true BRPI0519561A2 (pt) 2009-01-27

Family

ID=36615468

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0519561-6A BRPI0519561A2 (pt) 2004-12-27 2005-12-22 composiÇço farmacÊutica de hormânio da tireàide, embalagem farmacÊutica, e, mÉtodo de acondicionamento de uma composiÇço farmacÊutica de hormânio da tireàide

Country Status (10)

Country Link
US (1) US20060183804A1 (pt)
EP (1) EP1835897A2 (pt)
JP (1) JP2008525527A (pt)
KR (1) KR20070100720A (pt)
AU (1) AU2005322023A1 (pt)
BR (1) BRPI0519561A2 (pt)
CA (1) CA2589283A1 (pt)
IL (1) IL183824A0 (pt)
MX (1) MX2007007860A (pt)
WO (1) WO2006071844A2 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008073759A2 (en) * 2006-12-07 2008-06-19 Eli Lilly And Company An article comprising prasugrel
US7645801B2 (en) 2007-01-29 2010-01-12 Alaven Pharmaceutical Llc Reduced irritant enema for treatment of inflammatory bowel disease (IBD)
GB2450117A (en) * 2007-06-13 2008-12-17 Reckitt Benckiser Healthcare A water- and oxygen-occlusive blister tablet pack
US8375628B2 (en) * 2007-09-20 2013-02-19 Kamterter Products, Llc Seed testing method and apparatus
EP3578169B1 (en) 2009-02-26 2024-06-26 Glaxo Group Limited Pharmaceutical formulations comprising 4-{(1 r)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol
JP6081058B2 (ja) * 2009-03-19 2017-02-15 第一三共株式会社 包装により安定保存された固形製剤
GB0921075D0 (en) 2009-12-01 2010-01-13 Glaxo Group Ltd Novel combination of the therapeutic agents
ITMI20112066A1 (it) 2011-11-14 2013-05-15 Altergon Sa Preparazione farmaceutica orale monodose di ormoni tiroidei t3 e t4
EP3265078A1 (en) 2015-02-03 2018-01-10 Kadmon Pharmaceuticals, LLC Stable trientine formulations
US11077990B2 (en) * 2017-12-21 2021-08-03 Davion, Inc. Packaging system for medicated starch-based powder formulations
US20190209517A1 (en) * 2018-01-10 2019-07-11 Insys Development Company, Inc. Methods of stabilizing dronabinol

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU611181B2 (en) * 1987-07-27 1991-06-06 Constar International Inc. Improvements in and relating to packaging
BR8906385A (pt) * 1988-03-12 1990-08-28 Metal Box Plc Parede para uma embalagem e embalagem
ZA913312B (en) * 1990-05-02 1992-04-29 Zapata Industries Inc Polymer compositions containing oxygen scavenging compounds
US6709724B1 (en) * 1990-05-02 2004-03-23 W. R. Grace & Co.-Conn. Metal catalyzed ascorbate compounds as oxygen scavengers
CA2147148C (en) * 1990-05-02 2005-07-12 Bruce D. Zenner Polymer compositions containing oxygen scavenging compounds
US5202052A (en) * 1990-09-12 1993-04-13 Aquanautics Corporation Amino polycarboxylic acid compounds as oxygen scavengers
US5364555A (en) * 1991-04-30 1994-11-15 Advanced Oxygen Technologies, Inc. Polymer compositions containing salicylic acid chelates as oxygen scavengers
US5211875A (en) * 1991-06-27 1993-05-18 W. R. Grace & Co.-Conn. Methods and compositions for oxygen scavenging
US5225204A (en) * 1991-11-05 1993-07-06 Chen Jivn Ren Stable dosage of levothyroxine sodium and process of production
CN1096315A (zh) * 1992-11-24 1994-12-14 联邦科学及工业研究组织 除氧组合物
US5759653A (en) * 1994-12-14 1998-06-02 Continental Pet Technologies, Inc. Oxygen scavenging composition for multilayer preform and container
BR9711523A (pt) * 1996-09-23 1999-08-24 Amoco Corp Recipiente termopl stico garrafa termopl stica e processo para a fabrica-Æo de uma garrafa eliminadora de oxig-nio
US6083585A (en) * 1996-09-23 2000-07-04 Bp Amoco Corporation Oxygen scavenging condensation copolymers for bottles and packaging articles
US6863988B2 (en) * 1996-09-23 2005-03-08 Bp Corporation North America Inc. Oxygen scavenging monolayer bottles
JP3707899B2 (ja) * 1997-02-26 2005-10-19 株式会社大塚製薬工場 複室容器
JPH10287375A (ja) * 1997-04-14 1998-10-27 Material Eng Tech Lab Inc 酸素易変質性薬剤入り容器の包装体
US5981676A (en) * 1997-10-01 1999-11-09 Cryovac, Inc. Methods and compositions for improved oxygen scavenging
EP0939220B1 (de) * 1998-02-26 2003-11-12 ALSTOM (Switzerland) Ltd Verfahren zum sicheren Entfernen von Flüssigbrennstoff aus dem Brennstoffsystem einer Gasturbine sowie Vorrichtung zur Durchführung des Verfahrens
US6190696B1 (en) * 1998-06-08 2001-02-20 Pieter J. Groenewoud Stabilized thyroxine medications
DE19830246A1 (de) * 1998-07-07 2000-01-13 Merck Patent Gmbh Pharmazeutische Zubereitung
US6333087B1 (en) * 1998-08-27 2001-12-25 Chevron Chemical Company Llc Oxygen scavenging packaging
CA2299934C (en) * 1999-03-03 2006-09-19 Kuraray Co., Ltd. Oxygen absorptive resin composition
US6454965B1 (en) * 1999-03-24 2002-09-24 Chevron Phillips Chemical Company Lp Oxygen scavenging polymers in rigid polyethylene terephthalate beverage and food containers
MXPA01003219A (es) * 1999-08-06 2002-07-02 Plastipak Packaging Inc Recipiente plastico con una superficie interna tratada con carbon.
US6399101B1 (en) * 2000-03-30 2002-06-04 Mova Pharmaceutical Corp. Stable thyroid hormone preparations and method of making same
US6423776B1 (en) * 2000-05-02 2002-07-23 Honeywell International Inc. Oxygen scavenging high barrier polyamide compositions for packaging applications
GB2371498A (en) * 2000-08-03 2002-07-31 Johnson Matthey Plc Oxygen scavenging using PGM catalyst loaded grafted copolymer fibres
US6517776B1 (en) * 2000-11-03 2003-02-11 Chevron Phillips Chemical Company Lp UV oxygen scavenging initiation in angular preformed packaging articles
US6682791B2 (en) * 2001-02-07 2004-01-27 Sonoco Development, Inc. Packages and methods for differential oxygen scavenging
US6555581B1 (en) * 2001-02-15 2003-04-29 Jones Pharma, Inc. Levothyroxine compositions and methods
US6410156B1 (en) * 2001-03-06 2002-06-25 Honeywell International Inc. Oxygen scavenging polyamide compositions suitable for pet bottle applications
US6793994B2 (en) * 2001-03-07 2004-09-21 Honeywell International Inc. Oxygen scavenging polymer compositions containing ethylene vinyl alcohol copolymers
EP1243524A3 (en) * 2001-03-16 2004-04-07 Pfizer Products Inc. Pharmaceutical kit for oxygen-sensitive drugs
US6544611B2 (en) * 2001-08-01 2003-04-08 Arteva North America S.A.R.L. Oxygen scavenging PET based polymer
US20030183801A1 (en) * 2002-03-28 2003-10-02 Hu Yang Porous oxygen scavenging material

Also Published As

Publication number Publication date
EP1835897A2 (en) 2007-09-26
WO2006071844A8 (en) 2007-08-23
IL183824A0 (en) 2008-12-29
KR20070100720A (ko) 2007-10-11
CA2589283A1 (en) 2006-07-06
WO2006071844A2 (en) 2006-07-06
AU2005322023A1 (en) 2006-07-06
MX2007007860A (es) 2007-07-18
US20060183804A1 (en) 2006-08-17
JP2008525527A (ja) 2008-07-17
WO2006071844A3 (en) 2006-10-05

Similar Documents

Publication Publication Date Title
BRPI0519561A2 (pt) composiÇço farmacÊutica de hormânio da tireàide, embalagem farmacÊutica, e, mÉtodo de acondicionamento de uma composiÇço farmacÊutica de hormânio da tireàide
CY1122963T1 (el) Ουσια-φορεας φαρμακων και κιτ ουσιας-φορεα φαρμακων για αναστολη ινωσης
ECSP055671A (es) Nuevas quinazolinonas espirocondensadas y su uso como inhibidores de la fosfodiesteresa
IS7391A (is) ACC hindrar
MXPA06008352A (es) Una composicion farmaceutica.
BRPI0507198A (pt) derivados de bisariluréia
BRPI0912229A2 (pt) mistura para remoção de oxigênio, composição, artigo, mistura padrão, e, uso de uma mistura
SV2004001556A (es) Preparaciones acidas de insulina con establidad mejorada
CR8402A (es) Indazol-o-glucosidos sustitutos
SG148857A1 (en) N3 alkylated benzimidazole derivatives as mek inhibitors
BR0317822A (pt) Composição fluoroquìmica
RS52110B (en) DIPEPTIDIL PEPTIDASE INHIBITORS FOR TREATMENT OF DIABETES
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
NO20003472L (no) TTS som inneholder en antioksidant
NO20080220L (no) Formuleringer med hoy medikament belastning og doseringsformer
CO4920220A1 (es) Composiciones que contienen compuestos fluoroeter y metodos para inhibir su degradacion en presencia de un acido de lewis
EA200701228A1 (ru) Стабильные композиции фенофибрата с эфирами жирных кислот
PE20080400A1 (es) Composicion farmaceutica para la anticoncepcion y para reducir el riesgo de malformaciones congenitas
UY27610A1 (es) Combinación de inhibidores de ptm o inhibidores de la secreción de apob con fibratos para la utilización como medicamentos
AR038332A1 (es) Compuestos que son metabolitos del acido (3-{[(4-terc-butilbencil)-(piridin-3-sulfonil)amino]metil}fenoxi) acetico, composiciones farmaceuticas que los contienen, y procedimiento de determinacion
AR006616A1 (es) Derivados carboxilicos utiles como inhibidores de los receptores de las endotelinas y composiciones farmaceuticas que los contienen
RS51534B (en) NEW COMPOUND OF SINUSOID IF CURRENT INHIBITORS AND CALCIUM INHIBITOR AND PHARMACEUTICAL MIXTURE CONTAINED BY IT
EA200501164A1 (ru) Индазоламиды с аналгетической активностью
BR0308601A (pt) inibidores de carboxipeptidase b de plasma
NO20052680L (no) Forbedringsmiddel inneholdende brennstoff.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.